Prognostic value of glucose transporter 3 expression in hepatocellular carcinoma

Determining an effective biomarker for predicting the prognosis of patients with hepatocellular carcinoma (HCC) may improve patient survival rates. The present study aimed to investigate the expression of glucose transporter 3 (GLUT-3) in HCC and to determine its predictive value for the survival of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Hengjun, Hao, Yijie, Zhou, Xu, Li, Hongguang, Liu, Fangfeng, Zhu, Huaqiang, Song, Xie, Niu, Zheyu, Ni, Qingqiang, Chen, Min-Shan, Lu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924203/
https://www.ncbi.nlm.nih.gov/pubmed/31885715
http://dx.doi.org/10.3892/ol.2019.11191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924203/
https://www.ncbi.nlm.nih.gov/pubmed/31885715
http://dx.doi.org/10.3892/ol.2019.11191

Ejemplares similares